Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2010-9-2
pubmed:abstractText
MicroRNAs (miRNAs) play critical roles in embryonic development and are frequently deregulated in human cancers. The let-7 family members are tumor-suppressing miRNAs and are frequently downregulated in cancer cells. Lin-28 and Lin-28B are RNA-binding proteins highly expressed in embryonic tissues. Lin-28 proteins block let-7 precursors from being processed to mature miRNAs by inducing terminal uridylation and degradation of let-7 precursors. Here, we report that Lin-28B, but not Lin-28, is highly expressed in hepatocellular carcinoma (HCC). Lin-28B expression was more frequently noted in high-grade HCCs with high alpha-fetoprotein levels. Knockdown of Lin-28B by RNA interference in the HCC cell line HCC36 suppressed proliferation in vitro and reduced in vivo tumor growth in NOD/SCID mice. In contrast, overexpression of Lin-28B in the HCC cell line HA22T enhanced tumorigenicity. Overexpression of Lin-28B also induced epithelial-mesenchymal transition in HA22T cells and hence, invasion capacity. Large-scale real-time PCR array analysis revealed that, among 380 miRNAs, only let-7/mir-98 family members were regulated by Lin-28B. Lin-28B overexpression enhanced the expression of the known let-7 targets c-myc and HMGA2. It was also found that Lin-28B enhanced the expression of type 1 insulin-like growth factor receptor in a let-7-dependent manner. These results indicate that Lin-28B regulates tumor formation and invasion in HCC through coordinated repression of the let-7/mir-98 family and induction of multiple oncogenic pathways.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1460-2180
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
31
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1516-22
pubmed:meshHeading
pubmed-meshheading:20525879-Adolescent, pubmed-meshheading:20525879-Adult, pubmed-meshheading:20525879-Aged, pubmed-meshheading:20525879-Aged, 80 and over, pubmed-meshheading:20525879-Animals, pubmed-meshheading:20525879-Apoptosis, pubmed-meshheading:20525879-Blotting, Western, pubmed-meshheading:20525879-Carcinoma, Hepatocellular, pubmed-meshheading:20525879-Cell Adhesion, pubmed-meshheading:20525879-Cell Movement, pubmed-meshheading:20525879-Cell Proliferation, pubmed-meshheading:20525879-Gene Expression Regulation, Neoplastic, pubmed-meshheading:20525879-HMGA2 Protein, pubmed-meshheading:20525879-Humans, pubmed-meshheading:20525879-Liver Neoplasms, pubmed-meshheading:20525879-Male, pubmed-meshheading:20525879-Mice, pubmed-meshheading:20525879-Mice, Inbred NOD, pubmed-meshheading:20525879-Mice, SCID, pubmed-meshheading:20525879-MicroRNAs, pubmed-meshheading:20525879-Middle Aged, pubmed-meshheading:20525879-Neoplasm Invasiveness, pubmed-meshheading:20525879-RNA, Messenger, pubmed-meshheading:20525879-RNA-Binding Proteins, pubmed-meshheading:20525879-Reverse Transcriptase Polymerase Chain Reaction, pubmed-meshheading:20525879-Xenograft Model Antitumor Assays, pubmed-meshheading:20525879-Young Adult
pubmed:year
2010
pubmed:articleTitle
Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma.
pubmed:affiliation
Graduate Institute of Pathology, National Taiwan University, Taipei 100, Taiwan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't